drugset / Trial / NCT01886599
Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease
Non-randomizedParallel-groupOpen-label
Summary
The purpose of the study is to determine how Asunaprevir is handled by the body of subjects with kidney disease compared with subjects with normal kidney function
Timeline
- Start
- 2012-11
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asunaprevir | Small molecule | 100 mg | Oral |